FIELD: biotechnology.
SUBSTANCE: present invention relates to biotechnology, in particular to genetic markers on the 6th human chromosome that are associated with a favorable response to the treatment that purposefully affects toxin B Clostridium difficile (C. difficile) (TcdB), for example, an antibody to TcdB. These markers of the response to TcdB treatment are useful, among other things, for identifying patients who are most likely to be favorably affected by treatment using a treatment agent that specifically affects TcdB. The present invention also relates to antibodies, drugs and kits suitable together with markers of the response to TcdB treatment according to the present invention.
EFFECT: obtaining genetic markers for TcdB treatment.
30 cl, 11 dwg, 9 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING THE RISK OF FORMATION OF ANTI-HLA ANTIBODIES DURING TRANSFUSION OF BLOOD COMPONENTS | 2022 |
|
RU2793843C1 |
| METHOD FOR PREDICTION OF RECURRENCE RISK IN LEPROSY PATIENTS | 2008 |
|
RU2373529C1 |
| DIAGNOSTIC TECHNIQUE FOR PARKINSON DISEASE IN PATIENTS WITH OLFACTORY DYSFUNCTION | 2011 |
|
RU2478209C1 |
| METHOD AND SYSTEMS FOR PREDICTION OF HLA CLASS II-SPECIFIC EPITOPES AND CD4+ T-CELL CHARACTERIZATION | 2019 |
|
RU2826261C2 |
| PATIENT-SPECIFIC STEM CELL LINES DERIVED FROM HUMAN PARTHENOGENETIC BLASTOCYSTS | 2008 |
|
RU2511418C2 |
| METHOD FOR PREDICTION OF POLLEN BRONCHIAL ASTHMA | 2010 |
|
RU2441242C1 |
| METHOD OF PREDICTING SERIOUS COURSES OF LEPROTIC POLYNEURITES | 2007 |
|
RU2350955C1 |
| PEPTIDE SEQUENCES AND PEPTIDE COMPOSITIONS | 2008 |
|
RU2466737C2 |
| METHOD OF DETECTING PREDISPOSITION AND RESISTANCE TO DEVELOPMENT OF CYST ECHINOCOCCOSIS IN CHILDREN | 2008 |
|
RU2387383C1 |
| METHODS OF DISEASE TREATMENT BY MEANS OF STATISTICAL COPOLYMERS | 2005 |
|
RU2410115C2 |
